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Objectives: To determine the test–retest reliability and min-
imum detectable change scores for seven common clini-
cal measurements of muscle strength and physical func-
tion in a multiethnic sample of sarcopenic, malnourished 
men and women. 
Design: Each participant visited the laboratory seven times 
over 25 to 26 weeks. Reliability was assessed for each 
measurement from Familiarization 1 to Familiarization 
2 (R1), Familiarization 2 to baseline testing (R2), Famil-
iarization 3 to 12-week testing (R3), and Familiarization 
4 to 24-week testing (R4). 
Setting: Data were collected during a clinical trial at 23 
sites in the United States, Belgium, Italy, Mexico, Poland, 
Spain, Switzerland, and the United Kingdom. 
Participants: Sarcopenic, malnourished, older adults (N = 
257; n = 98 men aged 76.8 ± 6.3, n = 159 women aged 
75.9 ± 6.6). 
Measurements: During each visit, participants completed 
the Short Physical Performance Battery (SPBB) and iso-
metric handgrip and isokinetic leg extensor and flexor 
strength testing at a slow (1.05 rad/s) and fast (3.15 
rad/s) velocity. 
Results: Handgrip strength, gait speed, SPPB score, and iso-
kinetic leg extension and flexion peak torque (PT) had 
intraclass correlation coefficients (ICCs) that were sig-
nificantly greater than 0 (all ≥ 0.59) at R1, R2, R3, and 
R4, although most of these variables demonstrated sys-
tematic increases at R1, and several exhibited systematic 
variability beyond the baseline testing session. 
Conclusion: The ICCs and standard errors of the measure-
ment (SEMs) generally improved with familiarization, 
which emphasizes the need for at least one familiariza-
tion trial for these measurements in sarcopenic, malnour-
ished older adults. A three tier-approach to interpreting 
the clinical importance of statistically significant results 
that includes null hypothesis testing, examination and in-
terpretation of the effect magnitude, and comparison of 
individual changes with the SEM and minimum detect-
able change of the measurements used is recommended. 
Keywords: sarcopenia; aging; muscle strength; physical 
function; sensitivity 
Aging is associated with a progressive loss of skeletal muscle mass and strength known as sarcopenia. Sarco-
penia has multiple contributing factors, including chronic 
disease, a sedentary lifestyle, and malnutrition, and is asso-
ciated with deleterious consequences such as impaired mo-
bility, impaired ability to perform activities of daily living, 
greater risk of falls and fractures, loss of independence, and 
greater risk of death.1 In 2010, it was estimated that sarco-
penia affected more than 50 million people and would affect 
more than 200 million older adults through 2050.1 Conse-
quently, the identification and treatment of sarcopenia has 
become an emphasis of investigators and clinicians world-
wide, and identifying reliable measurements with which to 
identify and track sarcopenia is of great importance. 
In 2009, a group of representatives from the European 
Geriatric Medicine Society, the European Society for Clin-
ical Nutrition and Metabolism, the International Associa-
tion of Gerontology and Geriatrics—European Region, and 
the International Association of Nutrition and Aging formed 
the European Working Group on Sarcopenia in Older Peo-
ple (EWGSOP) to develop a clinical definition of and diag-
nostic criteria for sarcopenia.1 In its report, the EWGSOP 
developed primary outcome domains for interventions in 
sarcopenic older adults that included muscle strength and 
physical performance.1 The EWGSOP identified handgrip, leg 
extensor, and leg flexor strength as three primary muscle 
strength measurements and the Short Physical Performance 
Battery (SPPB) and usual gait speed as two primary tests 
of physical function for use in studies on sarcopenia,1 but 
they recognized that information on the feasibility of muscle 
strength testing was needed from a wider range of ages and 
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ethnicities in older adults.1 Furthermore, although studies 
have identified meaningful changes in gait speed and SPPB 
score in older adults with mild to moderate mobility impair-
ment and older sedentary adults,2,3 no previous studies have 
examined the reliability or of meaningful changes in sarco-
penic, malnourished older adults. Therefore, the purpose of 
this study was to determine the test–retest reliability and 
minimum detectable change (MDC) scores for seven com-
mon clinical measurements of muscle strength and physi-
cal function in a multiethnic sample of sarcopenic, malnour-
ished older men and women. 
Methods 
Participants 
Two hundred fifty-seven men (n = 98; mean age 76.8 ± 6.3, 
height 171.5 ± 7.4 cm, weight 77.8 ± 13.9 kg) and women (n 
= 159; mean age 75.9 ± 6.6, height 156.8 ± 7.7 cm, weight 
65.1 ± 12.7 kg) completed this study. All participants were 
aged 65–90 and were ambulatory and had a Subjective 
Global Assessment of Nutritional Status score of B or C,4 
a gait speed slower than 0.8 m/s or low handgrip strength 
(<20 kg for women, <30 kg for men), and a low skeletal 
muscle mass index according to whole-body dual x-ray ab-
sorptiometry (Class 1 or Class 2 sarcopenia),1 which clas-
sified them as sarcopenic, malnourished older adults. Fur-
ther details regarding inclusion and exclusion criteria have 
been published elsewhere.5 
The institutional review board or ethics committee at 
each of the study sites approved this study. All participants 
provided written informed consent before data collection, 
and a physician’s clearance was required to verify all inclu-
sion and exclusion criteria before enrollment. 
Experimental Design 
Each participant visited the laboratory on seven occasions 
over 25–26 weeks (Figure S1). At each visit, participants 
completed handgrip strength testing, the SPPB, and iso-
kinetic leg extension and flexion testing. Reliability was as-
sessed in men and women for each measurement from Fa-
miliarization 1 to Familiarization 2 (R1), Familiarization 2 
to baseline testing (R2), Familiarization 3 to 12-week testing 
(R3), and Familiarization 4 to 24-week testing (R4). 
These data were collected during a clinical trial (Clini-
calTrials.gov Identifier: NCT01191125) from February 2011 
to September 2012 at 23 sites in the United States, Belgium, 
Italy, Mexico, Poland, Spain, Switzerland, and the United 
Kingdom. Before any testing, all study staff were trained in 
a webinar and in person. This clinical trial involved two in-
tervention arms comparing an experimental oral nutritional 
supplement with a control oral nutritional supplement, but 
the aim of this substudy was to examine the test–retest re-
liability at each discrete testing phase (R1, R2, R3, R4), and 
the effects of the intervention arms were not examined, so 
the intervention did not affect the reliability of these tests 
reported herein. Baseline isokinetic muscle strength data 
from this clinical trial have been previously published.5 
Isometric Handgrip Strength Testing 
Maximal isometric handgrip strength was measured using 
a calibrated hand-held dynamometer (Jamar, Lafayette In-
strument, Lafayette, IN). Participants completed three tri-
als during which they were asked to squeeze the dynamom-
eter handle as forcefully as possible for 3 to 5 seconds. Each 
trial was recorded in kilograms, and the average of three tri-
als was used as the representative score. 
Short Physical Performance Battery 
The SPPB has been described previously.6 Each of its com-
ponents (balance tests, gait speed) were scored on a scale 
from 0 to 4, and a composite SPPB score was created from 
all three tests and used for analyses. Individual gait speed 
times during the 4-m course were converted to m/s and an-
alyzed separately from the composite SPPB score. 
Isokinetic Leg Extension Strength Testing 
For all isokinetic testing, participants were seated on a cal-
ibrated isokinetic dynamometer. They completed four sub-
maximal warm-up leg extension and leg flexion contractions 
at 25%, 50%, 75%, and 100% of their perceived effort at 
1.05 rad/s and 3.14 rad/s. After the warm-ups, each partic-
ipant completed three maximal leg extension and flexion 
contractions as quickly and explosively as possible at each 
velocity. The dynamometer software calculated peak torque 
(PT; Nm), which was the peak of the isokinetic torque-angle 
curve for each repetition. The repetition yielding the high-
est PT value at each velocity for each participant was used 
for further analysis.5 
Statistical Analyses 
The dependent variables used for analysis were handgrip 
strength (kg), gait speed (m/s), SPPB score, isokinetic leg 
extension PT at 1.05 rad/s and 3.14 rad/s (Nm), and iso-
kinetic leg flexion PT at 1.05 rad/s and 3.14 rad/s (Nm). 
Before statistical analyses were conducted, the data were 
checked for data entry errors. Errors or nonphysiological 
values were found for up to eight subjects, such as values 
that were outside of the equipment’s reporting capabilities. 
In each instance, all data for that participant were removed 
for that variable at the corresponding time point. Tables 1–3 
indicate where data entry errors were removed (indicated 
by a ˆ in the sample size column). 
Test–retest reliability was quantified for each of the de-
pendent variables between visits at R1, R2, R3, and R4. Two-
way analyses of variance (ANOVAs) were used to compare 
the means between visits for systematic variability. Cohen’s 
d effect sizes were calculated for the difference in means 
between visits. The likelihood that the magnitude of the 
effect was meaningful was determined using magnitude- 
based inferences using a smallest important effect value of 
0.2.7 Test–retest reliability was calculated by determining 
the intraclass correlation coefficient (ICC) using model “2, 
k.”8,9 The 95% confidence interval (CI) for each ICC2,k was 
also calculated.8,10,11 For measures of absolute reliability, the 
standard error of the measurement (SEM) was calculated as 
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the square root of the mean square error from the ANOVA 
table.9,12 The coefficient of variation (CV) was calculated as 
a normalized measure of the SEM.12 The MDC was computed 
by calculating a 95% interval about the SEM using the equa-
tion described by Weir.9 
All data were analyzed using SPSS version 22 (IBM, Ar-
monk, NY) and a custom-written spreadsheet (Excel, Mi-
crosoft, Redmond, WA). A type I error rate was set a pri-
ori at 5%. 
Results 
The means, standard deviations, and test–retest reliability 
statistics for the dependent variables at R1, R2, R3, and R4 
are provided in Tables 1–3, Table S1, and Figures S2 and S3. 
The ICCs for each dependent variable at R1, R2, R3, and R4 
were all greater than 0 (P ≤ .05). 
Discussion 
This is the first study to quantify the test–retest reliabil-
ity of commonly used clinical assessments of physical func-
tion in sarcopenic, malnourished older men and women over 
24 weeks. The results indicate that handgrip strength, gait 
speed, SPPB score, and isokinetic leg extension and flexion 
PT had ICCs that were greater than 0 (all ≥ 0.59) at all four of 
the test–retest time points, although most of these variables 
demonstrated systematic increases at R1, and several of the 
variables, such as gait speed, SPPB score, and leg flexion PT at 
1.05 rad/s, exhibited systematic variability beyond the base-
line testing session. Finally, ranges are provided for SEM and 
MDC scores (Table S1) for each of the tests that may be used 
to evaluate individual responses to interventions. 
All of the variables in the present study demonstrated 
relative reliability (ICCs) greater than 0 (Figure S2) at each 
of the time points assessed, although there were several 
variables for which the ICCs improved with familiariza-
tion. For example, the ICCs for gait speed, SPPB score, and 
isokinetic leg extension and flexion at 1.05 rad/s improved 
from R1 and/or R2 to R3 and/or R4 in men. Similarly, the 
ICCs for gait speed, handgrip strength, and isokinetic leg 
flexion at 3.14 rad/s improved from R1 and/ or R2 to R3 and/
or R4 in women, indicating that familiarization may increase 
the relative reliability of these variables in sarcopenic, mal-
nourished older men and women. 
The ICCs for isokinetic leg flexion in women were gen-
erally lower than for isokinetic leg extension (Figure S2), 
and this difference was more evident at 3.14 rad/s than 1.05 
rad/s. A previous study5 demonstrated that the variability 
in PT over three isokinetic repetitions was greater in sar-
copenic, malnourished elderly individuals than in those 
who were healthy, greater for leg flexion than extension, 
and greater at 3.14 rad/s than 1.05 rad/s. It also found a 
significant negative relationship between intraindividual 
variability and strength.5 Therefore, it is possible that the 
lower ICCs for leg flexion PT in the sarcopenic, malnour-
ished women in the present study was a function of lower 
leg flexion strength. It has been suggested that the inability 
of older adults to express strength reliably may be a direct 
consequence of detrimental age-related changes in neuro-
muscular function,13,14 and low leg flexion strength has been 
associated with greater risk of falls in older adults.15–17 Thus, 
although isokinetic leg flexion strength tests may exhibit 
lower reliability in sarcopenic, malnourished older adults, 
increasing leg flexion strength may be a way to enhance 
physical function in this population. 
With the exception of handgrip strength in women, gait 
speed in men, and isokinetic leg flexion PT at 3.14 rad/s in 
men, there were systematic increases for each variable from 
Familiarization 1 to 2 (at R1). Furthermore, gait speed, SPPB 
score, and leg extension and flexion PT at 1.05 rad/s exhib-
ited systematic variability beyond R1, although as previ-
ously described, “(s)upraoptimal sample sizes can produce. 
. . statistically significant effects that are likely to be clini-
cally useless.”7 Therefore, because of the large sample sizes 
in this study, magnitude-based inferences were used to mea-
sure the clinical meaningfulness of these changes objectively.7 
The magnitude-based inferences indicated that the signifi-
cant changes (P ≤ .05) in SPPB score at R2 (% chance of indi-
cated outcome (likely or trivial) = 60.0%; outcome = proba-
bly trivial), gait speed at R2 (54.3%; probably trivial) and R3 
(80.7%; likely trivial), and isokinetic leg flexion PT at 1.05 
rad/s at R2 (55.1%; probably trivial) and R4 (69.5%; proba-
bly trivial) for women were trivial (Tables 1–3). The meaning-
ful systematic changes at R1 further establish the importance 
of familiarization when using these variables in sarcopenic, 
malnourished older adults. Finally, the meaningful, system-
atic changes beyond R1 for variables such as gait speed in 
men and SPPB score in men and women demonstrate that sig-
nificant changes in large-scale clinical trials should be inter-
preted with caution and emphasize the need for a metric that 
provides a standard for researchers and clinicians to evaluate 
meaningful changes. In addition, because the SPBB is a com-
posite of several tests, researchers may choose to report the 
results of the individual tests and the composite SPBB score. 
Previous authors have used or suggested the use of the 
SEM and MDC as indices for investigators seeking to under-
stand the importance of an individual’s change based on the 
precision of the measurement.2,18 The SEM provides a quan-
tification of the trial-to-trial noise of a test and has been de-
scribed as an index that “links the reliability of the measure-
ment. . . to the standard deviation of the population.”9,18 The 
MDC is calculated as a 95% confidence interval (CI) about 
the SEM and has been described as “the difference needed 
between separate measures on a subject for the difference 
in the measures to be considered real.”9 In other words, in-
vestigators can be 95% confident that an individual’s change 
exceeds the measurement error if the change is equal to or 
greater than the MDC, although the 95% CI used to calcu-
late the MDC may be too conservative in a clinical setting. 
For example, a skeletal muscle mass index 1 standard devi-
ation unit below the mean in young adults (a value below 
the 68% confidence interval) has been used to define Class 
I sarcopenia, and a value 2 standard deviation units below 
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the mean (a value below the 95% CI) has been used to define 
Class II sarcopenia in older adults.1,19 Consequently, previous 
investigators have used the SEM as an indicator of clinically 
meaningful change for individuals on a test.2,18 Therefore, 
in addition to reporting the results of null hypothesis test-
ing, investigators may wish to report the proportion of sub-
jects with improvements that exceeded the SEM as a mod-
erate change and the MDC as a large change. Accordingly, a 
range of SEM and MDC values have been provided for each 
of the seven variables examined in this study (Table S1) that 
can be used to assess changes after an intervention on a sub-
ject-by-subject basis. 
Much like the ICCs, a qualitative examination suggested 
that the SEM and MDC tended to decrease with greater fa-
miliarization (Tables 1–3). In addition, MDC for isokinetic 
leg flexion PT in men and women were large, especially at 
3.14 rad/s (Table S1), suggesting that the absolute reliability 
of these measurements may be lower than that of the other 
measurements examined in this study. Therefore, combined 
with the low ICCs, isokinetic leg flexion may be unreliable 
in sarcopenic, malnourished older adults. 
Overall, the results of the present study indicated that 
handgrip strength, gait speed, SPPB score, and isokinetic leg 
extension and flexion PT had relative reliability scores that 
were greater than 0 at R1, R2, R3, and R4, although there 
were systematic increases from Familiarization 1 to Famil-
iarization 2 and the ICCs and SEMs generally improved with 
familiarization for most of the variables examined (Figure 
S4). Together, these data emphasize the need for at least one 
familiarization trial for these measurements in sarcopenic, 
malnourished older adults. These data also stress the im-
portance of control groups in interventions that use these 
measurements as outcome variables. Finally, in an attempt 
to interpret the clinical importance of statistically signifi-
cant results in clinical trials, a three-tiered approach that 
includes null hypothesis testing, examination and interpre-
tation of the effect magnitude, and comparison of individ-
ual changes relative to the SEM and MDC of the measure-
ments used is recommended. 
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Figure S1. Experimental timeline.
Figure S2. Intraclass correlation coefficients with 95% con-
fidence intervals for each of the dependent variables in 
men (A, B, C) and women (D, E, F) at Familiarization 1 
and Familiarization 2 (R1), Familiarization 2 and Base-
line Testing (R2), Familiarization 3 and 12-Week Testing 
(R3), and Familiarization 4 and 24-Week Testing (R4).
Figure S3. Minimum detectable change (MDC; solid dots) 
and percentage change (% Change; open squares) for 
each of the dependent variables in men (A, B, C) and 
women (D, E, F) at Familiarization 1 and Familiarization 
2 (R1), Familiarization 2 and Baseline Testing (R2), Fa-
miliarization 3 and 12-Week Testing (R3), and Familiar-
ization 4 and 24-Week Testing (R4).
Figure S4. Intraclass correlation coefficients and coefficients 
of variation for each dependent variables in men (A and 
C, respectively) and women (B and D, respectively) at Fa-
miliarization 1 and Familiarization 2 (R1), Familiariza-
tion 2 and Baseline Testing (R2), Familiarization 3 and 
12-Week Testing (R3), and Familiarization 4 and 24-Week 
Testing (R4).
Table S1. Absolute and Relative (Percentage of Grand Mean) 
Standard Error of the Measurement (SEM) and Minimum 
Detectable Change (MDC) Range
Figure S1. Experimental timeline. Handgrip strength, isokinetic leg extension strength, and the 
Short Physical Performance Battery were assessed at Familiarization 1, Familiarization 2, 
baseline testing, Familiarization 3, 12-week testing, Familiarization 4, and 24-week testing. 
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Supplementary Figure S2. Intraclass correlation coefficients with 95% confidence intervals for 
each of the dependent variables in men (A, B, C) and women (D, E, F) at R1, R2, R3, and R4. 
 
Figure S3. Minimum detectable change (MDC; solid dots) and percentage change (%Change; 
open squares) for each of the dependent variables in men (A, B, C) and women (D, E, F) at R1, 
R2, R3, and R4.  
 
Supplementary Figure S4. Intraclass correlation coefficients and coefficients of variation for 
each dependent variables in men (A and C, respectively) and women (B and D, respectively) at 
R1, R2, R3, and R4. 
 
Table S1. Absolute and Relative (Percentage of Grand Mean) Standard Error of the 
Measurement (SEM) and Minimum Detectable Change (MDC) Range 
Variable Absolute Relative (%; CV) 
 SEM MDC SEM MDC 
Men     
Grip strength, kg 1.51–1.98 4.18–5.50 5.35–6.68 14.83–18.52 
Gait speed, m/s 0.05–0.08 0.15–0.21 6.22–9.97 17.05–27.10 
SPPB score 0.57–0.84 1.57–2.32 5.97–9.39 16.57–26.08 
Isokinetic leg extension PT 1.05 rad/s, Nm 7.74–12.12 21.46–33.59 8.07–14.15 23.08–39.21 
Isokinetic leg flexion PT 1.05 rad/s, Nm 5.45–8.96 15.10–24.83 10.62–20.22 34.09–48.41 
Isokinetic leg extension PT 3.14 rad/s, Nm 5.27–8.11 14.61–22.47 9.42–15.63 26.11–43.32 
Isokinetic leg flexion PT 3.14 rad/s, Nm 5.10–6.59 14.13–18.28 15.71–22.25 43.54–61.67 
Women     
Grip strength, kg 0.96–1.56 2.67–4.31 5.28–9.30 14.65–25.75 
Gait speed, m/s 0.05–0.07 0.14–0.20 6.56–9.39 17.83–26.67 
SPPB score 0.76–0.86 2.21–2.38 9.01–10.49 26.12–29.06 
Isokinetic leg extension PT 1.05 rad/s, Nm 5.22–9.89 14.48–27.41 9.20–17.50 25.52–48.51 
Isokinetic leg flexion PT 1.05 rad/s, Nm 4.29–5.59 11.91–15.50 13.19–18.65 36.58–51.68 
Isokinetic leg extension PT 3.14 rad/s, Nm 4.19–5.49 11.61–15.23 12.30–16.15 34.08–44.77 
Isokinetic leg flexion PT 3.14 rad/s, Nm 4.39–5.44 12.17–15.09 24.25–27.58 67.20–76.46 
SPPB=Short Physical Performance Battery; PT=peak torque. 
